If a patient is found to have 2 lymph nodes positive with ECE s/p mastectomy, axillary dissection, tissue reconstruction, and lympho-venous bypass surgery, are there additional risks associated with delivery of PMRT?
Would the presence of tissue reconstruction and lympho-venous bypass ever impact your dose/fractionation or PMRT field design in this case?